Markley H G, Cheronis J C, Piepho R W
Neurology. 1984 Jul;34(7):973-6. doi: 10.1212/wnl.34.7.973.
We conducted a double-blind, placebo-controlled crossover study of verapamil HCl in the prophylaxis of chronic migraine headaches. Verapamil significantly reduced both headache frequency and duration with few side effects. The drug may be useful for a segment of the migraine population refractory to other prophylactic agents or for those who cannot tolerate the side effects of other drugs.
我们进行了一项关于盐酸维拉帕米预防慢性偏头痛的双盲、安慰剂对照交叉研究。维拉帕米显著降低了头痛频率和持续时间,且副作用较少。该药物可能对一部分对其他预防药物无效或无法耐受其他药物副作用的偏头痛患者有用。